|
Bei
Sun, Ha-Li Li, Yue Gao, Jun Xu, Hong-Chi Jiang, Department of
General Surgery, First Clinical Hospital, Harbin Medical University,
Harbin 150001, China
Correspondence to: Bei Sun, Department of General Surgery, First
Clinical Hospital, Harbin Medical University, Harbin 150001,China.
sunbei70@163.net
Telephone: +86-451-3600281
Fax: +86-451-3600286
Received: 2002-10-30
Accepted: 2002-12-24
Abstract
AIM: To analyze factors predisposing to the infections associated
with severe acute pancreatitis (SAP) and to work out ways for its
prevention.
METHODS:
Total 208 cases of SAP treated in this hospital from Jan. 1980 to
Dec. 2001 were retrospectively analyzed.
RESULTS:
Statistical difference in the incidence of the aforementioned
infections was found between the following pairs: between the groups
of bloody or non-bloody ascites, paralytic ileus lasting shorter or
longer than 5 days, Ranson scores lower or higher than 5, hematocrit
lower or higher than 45 %, CT Balthazar scores lower or higher than
7 and between 1980.1-1992.6 or 1992.7-2001.12 admissions (x2>3.84,
P<0.05), while no statistical difference was established between
the groups of biliogenic and non - biliogenic pancreatitis, serum
amylase <200 U/L and ≥200 U/L, serum calcium <2 mmol /L and
≥ 2 mmol/L or groups of total parenteral nutrition shorter or
longer than 7 days (?2<3.84, P>0.05).
CONCLUSION:
Occurrence of infection in patients with SAP is closely related with
bloody ascites, paralytic ileus ≥5 days, Ranson scores ≥5,
hematocrit ≥45 % and CT Balthazar Scores ≥7, but not with
pathogens, serum calcium and total parenteral nutrition (TPN).
Comprehensive prevention of pancreatic infection and practice of
individualized therapy contribute to reducing the incidence of
infection.
Sun
B, Li HL, Gao Y, Xu J, Jiang HC. Factors predisposing to severe
acute pancreatitis: evaluation and prevention. World J Gastroenterol
2003; 9(5): 1102-1105
http://www.wjgnet.com/1007-9327/9/1102.asp
INTRODUCTION
Severe acute pancreatitis (SAP) characterized by atrocious
progression, multi-complications and unquenchable mortality rate is
a very dangerous acute abdomen[1-3]. SAP progresses in
two consecutive stages: the earlier stage marked by serious
physiological disorder and the later stage presenting with necrosis
and infection. The earlier-stage mortality mainly caused by
hypovolaemia, shock, adult respiratory distress syndromes (ARDS) and
cardiac or renal insufficiency has been remarkably lowered as a
result of the improvement on intensive care for severe diseases in
recent years, however the later-stage mortality as a consequence of
pancreatic or peri- pancreatic infections and their complications is
still above 50 %[4-6]. Though the primary choice for
pancreatic infection was surgery, surgical intervention can not
obviously bring down the formidable mortality, thus rendering it
extremely valuable to study the predisposing factors and to work out
ways for effective prevention.
MATERIALS
AND METHODS
Clinical data
Total 208 SAP cases treated in this hospital since Jan. 1980 to Dec.
2001 were selected, which consisted of 112 males and 96 females with
an average age of 49 ranging from 18 to 82 years old. All the
patients were diagnosed by clinical presentations, biochemical
findings and CT scanning on pancreas according to the universal
standard for SAP diagnosis in China. Among these 208 cases, 68 were
diagnosed as secondary pancreatic infection and the other 114
non-infections. 94 cases admitted between Jan. 1980 and June. 1992
underwent operations in the earlier stage, while the other 114 cases
between July 1992 and Dec. 2001 were treated by the principle of
"Individualized therapy", which, with emphasis on
conservative management in the earlier stage, exploited
comprehensive individualized treatments to prevent secondary
pancreatic infection. Preventive measures include: (1) volume
supplementation, shock correction and protection against multiple
organ dysfunction syndrome (MODS); (2) improving pancreatic
micro-circulation; (3) decontamination of intestinal tract to
facilitate the recovery of gastrointestinal function; (4) preventive
prescription of antibiotics; (5) nutritional support; (6) peritoneal
lavage or drainage in case of retention with a great amount of
exudates in the abdominal cavity. The criteria for diagnosis of
pancreatic infection are: (1) body temperature continuously ≥38.5 ℃,
white blood cell count (WBC)≥20×109/L and signs of peritoneal irritation in more than
2 quadrants; (2) air bubbles in necrotic tissue of the pancreas by
enhanced CT scanning; (3) bacteria found by culture or smear
examination on fine needle aspirate.
Statistical
analysis
All the data was analyzed by chi-square test.
RESULTS
Analysis of factors inducing pancreatic infection
Table 1 shows that statistical difference existed between the groups
of bloody and non-bloody ascites, paralytic ileus lasting shorter or
longer than 5 days, Ranson scores lower or higher than 5, hematocrit
lower or higher than 45 %, CT Balthazar scores lower or higher than
7 and between 1980.1-1992.6 or 1992.7-2001.12 admissions (x2>3.84,
P<0.05), while no statistical difference was found between the
groups of biliogenic and non - biliogenic pancreatitis, serum
amylase <200 U/L and ≥200 U/L, serum calcium < 2 mmol /L and
≥2 mmol/L or groups of total parenteral nutrition shorter or
longer than 7 days (x2 <3.84, P>0.05).
Table
1 Factors predisposing
to infections associated with SAP
| Factors |
Total
cases |
Incidence
of infections |
P
values |
| cases |
% |
x2 |
| Admission |
| 1980.1-1992.6 |
94 |
40 |
42.6 |
7.58 |
<0.01 |
| 1992.7-2001.12 |
114 |
28 |
24.6 |
|
|
| Ascites |
| Non-bloody |
156 |
40 |
25.6 |
14.1 |
<0.01 |
| Bloody |
52 |
28 |
53.8 |
|
|
| Paralytic
ileus |
| <5
days |
150 |
43 |
28.7 |
3.96 |
<0.05 |
| ≥5
days |
58 |
25 |
43.1 |
|
|
| Ranson
Scores |
| <5 |
144 |
40 |
27.8 |
5.14 |
<0.05 |
| ≥5 |
64 |
28 |
43.8 |
|
|
| Hematocrit |
| <45
% |
128 |
35 |
27.3 |
4.33 |
<0.05 |
| ≥45
% |
80 |
33 |
41.2 |
|
|
| CT
Balthazar Scores |
| <7 |
138 |
38 |
27.5 |
4.95 |
<0.05 |
| ≥7 |
70 |
30 |
42.9 |
|
|
| Etiology |
| Biliogenic
SAP |
90 |
35 |
38.9 |
2.77 |
>0.05 |
| Non-biliogenic
SAP |
118 |
33 |
28.0 |
|
|
| Serum
amylase |
| <200
U/L |
83 |
25 |
30.1 |
0.41 |
>0.05 |
| ≥200
U/L |
125 |
43 |
34.4 |
|
|
| Serum
calcium |
| <2
mmol/L |
88 |
34 |
38.6 |
2.45 |
>0.05 |
| ≥2
mmol/L |
120 |
34 |
28.3 |
|
|
| TPN |
| <7
days |
126 |
37 |
29.4 |
1.61 |
>0.05 |
| ≥7
days |
82 |
31 |
37.8 |
|
|
DISCUSSION
More than 80 % of mortality in SAP is related with infection, mainly
the secondary infection in the tissues[7-9]. Secondary
pancreatic infections including infective pancreatic necrosis,
pancreatic abscess and infective pancreatic psudocyst are
responsible for more than 90 % of systematic infections and
predispose to acute injury of gastric mucosa, hemorrhage in the
abdominal cavity, fistula of digestive tract and multiple organ
failure. Baron et al deemed that the morbidity of secondary
infection was 30-70 %[10], while a morbidity of 32.7 %
was demonstrated in this study. The mechanisms of secondary
infection have not been fully elucidated yet. Gastrointestinal
paralysis and edema of the intestinal mucosa caused by pancreatic
enzymes and many other bioactive and toxic substances released in
the acute stage give rise to disorder and translocation of bacterial
clusters as well as atrophy of the intestinal mucosa lack of
stimulus from food as a result of long-term (more than 1 week)
gastric decompression. TPN impairs the mononuclear phagocytic system
and thus weakens the intestinal immunity, which in turn promotes
intestinal bacteria translocation making secondary infection
inevitable[11-13]. In our experience the main cause of
mortality in the later stage of SAP (after 2 weeks) was pancreatic
infection or multiple organ system failure (MOSF). To prevent
secondary pancreatic infection is essential to reducing the
mortality of SAP. Therefore it is of chief importance to understand
the factors related to pancreatic infection before any prevention is
undertaken against it[14,15].
Our
data did not indicate obvious relationship between the incidence of
secondary infection and etiology of pancreatitis, serum amylase,
serum calcium and TPN. Biliogenic pancreatitis is generally
considered as a high risk factor to pancreatic infection, since it
is always accompanied by biliary tract infection. However such
consequence is not confirmed by our data, which may be that the
secondary infection of SAP is mainly entero-genic. Whether TPN
increases the incidence of secondary infection is still
controversial[16-18], but there is an evidence that
long-term central venous catheter deposit, tedious intubating
manipulation and improper nursing of catheter lead to certain
catheter-related infections, which are proved to give priority to G-
bacteria, whereas in our study, to G+ bacteria instead. Accordingly,
it may be concluded that TPN has no marked relationship with
infections caused by intestinal bacteria translocation.
According
to our data, bloody ascites, paralytic ileus ≥5 days, Ranson
scores ≥5, hematocrit ≥45 % and CT Balthazar scores ≥7
predispose to secondary pancreatic infection. Great amount of bloody
ascites indicating severe hemorrhage and necrosis of the pancreas
and dissemination of inflammatory mediators throughout the abdominal
cavity can not be absorbed in most cases if not timely eliminated,
and it acts as an important initiator giving rise to or worsening
the ongoing intra-peritoneal infection. The relationship between
pancreatic infection and the extent of pancreatic or peri-pancreatic
necrosis graded by CT Balthazar scoring has been confirmed by many
investigations[19,20], but intestinal malfunction as an
initiative to bacteria translocation and pancreatic infection has
been ignored although the latter two are being investigated more
deeply, producing the concept of preventive prescription of
intra-intestinal antibiotics in view of pancreatic infection.
Recently, some traditional Chinese medical doctors, who have
achieved prominent efficacy using prescriptions emphasized on Tungli
(an acupoint) and purgation, found the earlier the intestinal
malfunction corrected, the lower the incidence of secondary
pancreatic infection in the later stage was, otherwise the high
incidence of both MOSF in the earlier stage and secondary pancreatic
infection in the later stage persists. Ranson's
grading system as a standard to
evaluate the severity of acute pancreatitis and to determine its
prognosis went into practice in 1974 and has been proved efficient
ever since by both domestic and foreign researchers. In our study,
the coincidence of secondary infection with the Ranson's
score of SAP was established.
Recently,
some scholars pointed out that pachyhemia poses threat in the
earlier stage of SAP, as Hayakawa demonstrated that apparent
reduction of circulation volume and pachyhemia existed in patients
with SAP and suggested hemoglobin >150 g/L as a preliminary
indicator to pachyhemia[21]. Baillargeon's
study demonstrated that
pachyhemia with hematocrit ≥47 % at admission or HCT staying high
in 24 hours after admission points to SAP and helps evaluate the
extent of pancreatic necrosis and predict the onset of MOSF[22,23].
In this study, hematocrit was obtained in the earlier stage of SAP
before any intervention, which precisely reflected the extent of
pachyhemia. Our data further demonstrated that pachyhemia is closely
related with secondary infection of SAP, but the mechanism was
unknown. We deem it may be that the exudation of large amount of
plasma from circulation into the third space through the capillary
bed with enhanced permeability by activated pancreatic enzymes and
other vaso-active substances produced by SAP results in systemic
pachyhemia, elevated HCT count and deteriorated pancreatic
micro-circulation and eventually leads to pancreatic infection.
We also found that the incidence of pancreatic infection in the
group admitted in 1992-07/2001-12 was significantly lower than that
in the group of 1980-01/1992-06 admission. The reasons were: (1)
application of "individualized
therapy" on SAP; (2) adoption of comprehensive prevention
against secondary pancreatic infection. The patients admitted during
1980-01/1992-06 underwent operations in the earlier stage, which as
a matter of fact, not only aggravated the instability of circulation
in the earlier stage or even caused shock rather than reduced the
incidence of MOSF, but also destroyed the integrity of the pancreas,
hampered its self-healing process, gave rise to further ischemia and
necrosis after the operation and rendered it a site vulnerable to
bacteria translocation increasing the incidence of pancreatic
infection.
While
in recent years, as to the patients admitted in 1992-07/2001-12 "Individualized
therapy" was adopted, which with emphasis on conservative
management in the earlier stage employs comprehensive individualized
treatments to prevent secondary pancreatic infection and alternates
to surgical operations if failed. Comprehensive preventions include:
(1) blood volume supplementation, shock correction and especially
preventions against multi-organ low perfusion injury and MOSF in the
earlier stage of SAP. Ischemia and anoxia are responsible for
pancreatic necrosis, damage to gastrointestinal mucosal barrier,
bacteria translocation and even malfunction of the heart, the
kidneys or the lungs; (2) to improve the microcirculation: by
decreasing the fragility of RBC and lowering blood viscosity, the
combined administration of Dextran, Saliva miltorrhiza, Ca2+-blocker
and large dosages of dexamethason maintains hyperdynamic
circulation, which is efficient in oxygen transportation. Therefore,
pancreatic and systemic micro-circulation is protected and
intracellular Ca2+ overload prevented, resulting in
alleviated necrosis of the pancreatic acinar, suppression of various
imflammatory mediators and lowered incidence of micro-thrombocytosis;
(3) intestinal decontamination to facilitate the recovery of
gastrointestinal function: traditional Chinese cathartic herbs
including castor oil and magnesium sulfate were early administrated
to achieve decontamination, which not only decrease the population
of intestinal bacteria but also promote gastrointestinal peristalsis
eliminating "dead
cavities". Translocation of intestinal bacteria as the
principal cause of secondary infection is thus constrained.
Moreover, physical therapy targeted at the gastrointestinal tract is
helpful for the recovery of its function; (4) preventive
administration of antibiotics: the antibiotics against G- bacilli
especially those capable of passing through the blood-pancreas
barrier such as third generation cephalosporin, imipenem, tinidazole,
etc are effective, while other antibiotics such as first generation
cephalosporin, ampicillin, amikacin, etc have been proved
ineffective thus improper for prescription[24,25]. (5)
nutritional support: enough energy should be supplemented by means
of EN (enteral nutrition) or TPN (total parenteral nutrition) to
stop self burning, potentiate resistance against infection and
accelerate tissue healing[26]. Recent study shows that
pure TPN reduces the production of saliva, gastric juice, intestinal
juice and bile, which are essential to the integrity of
gastrointestinal barrier and function. Though a necessary part of
the therapeutic planning, single application of TPN can not reverse
hyper-catabolism in the earlier stage but together with fasting,
enhances the permeability of the intestinal mucosa. It is suggested
that TPN should give way to EN when the digestive tract restore the
ability to bear food load; (6) peritoneal lavage and drainage of
effusion[27]: Beger argued that severe intra-peritoneal
hyperbaric status might lead to the death of patients with SAP[28,29].
When large amount of ascites develops in SAP patients, active
peritoneal lavage or ultrasonic B or CT guided drainage through a
small abdominal incision should be employed to eliminate activated
inflammatory mediators and toxic peritoneal exudates, so that toxin
intake and intra-peritoneal hyperbaric status can be alleviated. By
these measures certain cases, on which conservative treatment is
ineffective, avoid the operations aimed at establishing peri-pancreatic
drainage in the earlier stage and the incidence of secondary
pancreatic infection is thus reduced.
REFERENCES
1
Ammori BJ, Fitzgerald P, Hawkey P, McMahon MJ. The early
increase in intestinal permeability and systemic endotoxin
exposure in patients with severe
acute pancreatitis is not associated with systemic bacterial
translocation:
molecular investigation of microbial
DNA in the blood. Pancreas 2003; 26: 18-22
2
Hartwig W, Werner J, Muller CA, Uhl W, Buchler MW. Surgical
management of severe pancreatitis including sterile
necrosis. J Hepatobiliary Pancreat
Surg 2002; 9: 429-435
3
Hartwig W, Werner J, Uhl W, Buchler MW. Management of
infection in acute pancreatitis. J Hepatobiliary Pancreat Surg
2002; 9: 423-428
4
Howard TJ, Temple MB. Prophylactic antibiotics alter the
bacteriology of infected necrosis in severe acute pancreatitis.
J Am Coll Surg
2002; 195: 759-767
5
Balthazar EJ. Complications of acute pancreatitis: clinical
and CT evaluation. Radiol Clin North Am 2002; 40: 1211-1227
6
Gecelter G, Fahoum B, Gardezi S, Schein M. Abdominal
compartment syndrome in severe acute pancreatitis: an
indication
for a decompressing laparotomy? Dig
Surg 2002; 19: 402-405
7
Uhl W, Warshaw A, Imrie C, Bassi C, McKay CJ, Lankisch PG,
Carter R, Di Magno E, Banks PA, Whitcomb DC, Dervenis C,
Ulrich CD, Satake K, Ghaneh P,
Hartwig W, Werner J, McEntee G, Neoptolemos JP, Buchler MW. IAP
guidelines for the
surgical management of acute
pancreatitis. Pancreatology 2002; 2: 565-573
8
Samel S, Lanig S, Lux A, Keese M, Gretz N, Nichterlein T,
Sturm J, Lohr M, Post S. The gut origin of bacterial
pancreatic
infection during acute experimental
pancreatitis in rats. Pancreatology 2002; 2: 449-455
9
Olah A, Belagyi T, Issekutz A, Gamal ME, Bengmark S.
Randomized clinical trial of specific lactobacillus and fibre
supplement to early enteral nutrition
in patients with acute pancreatitis. Br J Surg 2002; 89: 1103-1107
10
Baron TH, Morgan DE. Acute necrotizing pancreatitis. N Engl J
Med 1999; 340: 1412- 1417
11
Karsenti D, Bourlier P, Dorval E, Scotto B, Giraudeau B,
Lanotte R, de Calan L, Mesny J, Lagarrigue F, Metman E.
Morbidity
and mortality of acute pancreatitis:
prospective study in a French university hospital. Presse Med 2002;
31: 727-734
12
Bose SM, Verma GR, Mazumdar A, Giridhar M, Ganguly NK.
Significance of serum endotoxin and antiendotoxin antibody
levels in predicting the severity of
acute pancreatitis. Surg Today
2002; 32: 602-607
13
Moriguchi T, Hirasawa H, Oda S, Shiga H, Nakanishi K, Matsuda
K, Nakamura M, Yokohari K, Hirano T, Hirayama Y,
Watanabe E. A patient with severe
acute pancreatitis successfully treated with a new critical care
procedure. Ther
Apher 2002; 6: 221-224
14
Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamura
M. Continuous hemofiltration/ hemodiafiltration in critical
care. Ther Apher 2002; 6: 193-198
15
Bank S, Singh P, Pooran N, Stark B. Evaluation of factors
that have reduced mortality from acute pancreatitis over the
past 20 years. J Clin Gastroenterol
2002; 35: 50-60
16
Norton ID, Clain JE. Optimising outcomes in acute
pancreatitis. Drugs 2001;
61: 1581-1591
17
Beger HG, Rau B, Isenmann R. Prevention of severe change in
acute pancreatitis: prediction and prevention.
J Hepatobiliary Pancreat Surg 2001;
8: 140-147
18
Gloor B, Muller CA, Worni M, Martignoni ME, Uhl W, Buchler
MW. Late mortality in patients with severe acute pancreatitis.
Br J Surg 2001; 88: 975-979
19
Al-Omran M, Groof A, Wilke D. Enteral versus parenteral
nutrition for acute pancreatitis. Cochrane Database Syst Rev
2001; 2: CD002837
20
Gurlich R, Peskova M, Lukas M, Maruna P. Pathophysiology of
development of acute pancreatitis. Sb Lek
1999; 100: 269-277
21
Hayakawa T. Physiopathology and treatment of severe acute
pancreatitis. Nippon Naika Gakkai Zasshi 2001; 90: 434-439
22
Baillargeon JD, Orav J, Ramagopal V, Tenner SM, Banks PA.
Hemoconcentration as an early risk factor for
necrotizing pancreatitis. Am J
Gastroenterol 1998; 93: 2130-2135
23
Wyncoll DL. The management of severe acute necrotizing
pancreatitis: an evidence-based review of the literature.
Intensive Care Med 1999; 25: 146-156
24
Kramer KM, Levy H. Prophylactic antibiotics for severe acute
pancreatitis: the beginning of an era. Pharmacotherapy
1999; 19: 592-602
25
Lehocky P, Sarr MG. Early enteral feeding in severe acute
pancreatitis: can it prevent secondary pancreatic infection?
Dig Sur 2000; 17: 571-577
26
Okabe A, Hirota M, Nozawa F, Shibata M, Nakano S, Ogawa M.
Altered cytokine response in rat acute pancreatitis
complicated with endotoxemia.
Pancreas 2001; 22: 32-39
27
Gloor B, Uhl W, Muller CA. The role of surgery in the
management of acute pancreatitis. Can J Gastroenterol
2000; 14: 136D-140D
28
Beger HG, Isenmann R. Surgical management of necrotizing
pancreatitis. Surg Clin North Am 1999; 79: 783-800
29
Bradley EL III, Allen K. A prospective longitudinal study of
observation versus surgical intervention in the management
of necrotizing pancreatitis. Am J
Surg 1991; 161: 19-24
Edited
by Zhang
JZ
| |